Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2000
10/12/2000WO2000059924A1 Methods and reagents for modulating caspase-mediated apoptosis
10/12/2000WO2000059919A1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION
10/12/2000WO2000059881A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000WO2000059867A1 Hydroxyphenyl derivatives with hiv integrase inhibitory properties
10/12/2000WO2000059863A1 Disodium salts, monohydrates, and ethanol solvates
10/12/2000WO2000059549A1 Antisense oligonucleotide compositions and methods for the modulation of jnk proteins
10/12/2000WO2000059548A1 Polyethyleneimine:dna formulations for aerosol delivery
10/12/2000WO2000059545A1 Modification of sexual behaviour in animals and pest control
10/12/2000WO2000059542A1 Method for a programmed controlled ovarian stimulation protocol
10/12/2000WO2000059536A1 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
10/12/2000WO2000059535A2 suPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF
10/12/2000WO2000059534A1 Method and compositions for preventing or reducing hiv infection by use of inhibitors for leucine aminopeptidase
10/12/2000WO2000059533A1 Use of asparaginase and glutaminase to treat autoimmune disease and graft versus host disease
10/12/2000WO2000059532A1 The use of domains of type iv collagen t inhibit angiogenesis an tumour growth
10/12/2000WO2000059531A2 Therapeutic uses of bpi protein products in bpi-deficient humans
10/12/2000WO2000059530A1 Use of soluble tumor necrosis factor receptor for treatment heart failure
10/12/2000WO2000059529A1 Mouse edg1
10/12/2000WO2000059528A1 Desleucyl glycopeptide antibiotics and methods of making same
10/12/2000WO2000059527A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
10/12/2000WO2000059525A2 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES
10/12/2000WO2000059515A2 Immunomodulating polymers
10/12/2000WO2000059485A2 Pharmaceutical compositions comprising in combination a bisphosphonate and a matrix metalloproteinase inhibitor
10/12/2000WO2000059476A1 Methods for fine powder formation
10/12/2000WO2000059462A1 Composition for cosmetic and dermatological skin care
10/12/2000WO2000059424A1 Vacuum assisted closure system with provision for introduction of agent
10/12/2000WO2000049132A9 Uses of transgenic animals containing a type x collagen mutant
10/12/2000WO2000038747A3 Absorbent article composition and method of use for sequestering skin irritants
10/12/2000WO2000037494A3 Chlamydia trachomatis antigens
10/12/2000WO2000035939A3 Connective tissue growth factor fragments and methods and uses thereof
10/12/2000WO2000033869A3 Use of human prostrate cell lines in cancer treatment
10/12/2000WO2000032803A3 Novel nucleic acid transferring agents, compositions containing them and uses
10/12/2000WO2000027196B1 Use of gm-csf to inhibit development of drug resistance in hiv+ patients
10/12/2000WO2000023594A9 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)
10/12/2000WO2000020587A3 Cancer associated antigens and uses therefor
10/12/2000WO2000020449A3 MODIFIED TGF-β SUPERFAMILY PROTEINS
10/12/2000WO2000020446A3 Bax-mediated apoptosis modulating reagents and methods
10/12/2000WO2000018918A9 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
10/12/2000WO2000015790A9 Leptin induced genes
10/12/2000WO2000005250A9 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides
10/12/2000WO2000004046A3 Multiple splice variants of the mu-opioid receptor gene
10/12/2000WO1999064594A9 Genes and gene expression products that are differentially regulated in prostate cancer
10/12/2000WO1999064039A9 Bradykinin antagonists
10/12/2000WO1999051188A9 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/12/2000WO1999041376A8 Retinoblastoma protein complexes and retinoblastoma interacting proteins
10/12/2000WO1998025597A3 Method for treating and preventing heart failure and ventricular dilatation
10/12/2000WO1997036919A3 Cytokine designated lerk-8
10/12/2000DE19915862A1 Verwendung von molekulargewichtserweitertem Hirudin als Antikoagulans bei der extrakorporalen Nierenersatztherapie Use of molekulargewichtserweitertem hirudin as an anticoagulant in extracorporeal renal replacement therapy
10/12/2000DE10004815A1 Human sodium-phosphate cotransporter Npt2B, useful e.g. for identifying agents for treating hyper- and hypo-phosphatemia, and related nucleic acid
10/12/2000CA2487952A1 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
10/12/2000CA2370782A1 Desleucyl glycopeptide antibiotics and methods of making same
10/12/2000CA2369446A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000CA2369024A1 Negative pressure wound therapy system with provision for introduction of agent
10/12/2000CA2368387A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
10/12/2000CA2368230A1 Use of asparaginase and glutaminase to treat autoimmune disease and graft versus host disease
10/12/2000CA2368185A1 Polyethyleneimine:dna formulations for aerosol delivery
10/12/2000CA2368183A1 Supar stimulating activity of tcupa-mediated fibrinolysis and different uses thereof
10/12/2000CA2368017A1 Use of erbb receptor ligands in treating diabetes
10/12/2000CA2367943A1 Therapeutic uses of bpi protein products in bpi-deficient humans
10/12/2000CA2367403A1 Dsp-9 dual-specificity map kinase phosphatase
10/12/2000CA2367378A1 Molecules of the immune system
10/12/2000CA2367294A1 Prediction of risk of interstitial lung disease
10/12/2000CA2367109A1 Dsp-4 dual-specificity map kinase phosphatase
10/12/2000CA2366895A1 Immunomodulating polymers
10/12/2000CA2365970A1 Chemokine-derived synthetic peptides
10/12/2000CA2365825A1 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
10/12/2000CA2365824A1 Use of soluble tumor necrosis factor receptor for treatment heart failure
10/12/2000CA2365575A1 Influenza virus hemagglutinin-binding peptides
10/12/2000CA2365548A1 Protein-protein from s. cerevisiae and methods of using same
10/12/2000CA2365545A1 Base sequences for expression of therapeutic genes and medicaments for gene therapy
10/12/2000CA2365526A1 Recombinant influenza viruses for vaccines and gene therapy
10/12/2000CA2365421A1 Vesicle associated proteins
10/12/2000CA2365221A1 Compositions for the treatment and diagnosis of breast cancer and methods for their use
10/12/2000CA2365040A1 Hob-bp2h compositions, methods and uses thereof
10/12/2000CA2364512A1 Compound for inhibiting the influx of polymorphonuclear leukocytes (pmns) in a tissue, its selection, pharmaceutical compositions and use
10/12/2000CA2303702A1 Growth hormone and growth hormone releasing hormone compositions
10/11/2000EP1043403A1 Novel method for identifying antibacterial compounds
10/11/2000EP1043397A1 IDENTIFICATION OF NOVEL SUBSTRATE I-TRAF OF IKK-i KINASE
10/11/2000EP1043395A1 Novel guanosine triphosphate (gtp)-binding protein conjugate type receptor proteins
10/11/2000EP1043333A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF
10/11/2000EP1043332A1 Dipeptides comprising cyclopentan-beta-amino acids
10/11/2000EP1043328A1 Novel physiologically active substance sulphostin, process for producing the same, and use thereof
10/11/2000EP1043322A1 Vitamin e derivatives
10/11/2000EP1043028A1 Method for preventing/remedying mastitis
10/11/2000EP1043027A1 Treatment of multiple sclerosis with a combination of Interferon and Growth hormone
10/11/2000EP1043026A2 Melanoma therapy
10/11/2000EP1043025A2 Renal cell carcinoma treatment
10/11/2000EP1043024A2 Chronic myeloid leukemia (cml) therapy
10/11/2000EP1042674A1 148 human secreted proteins
10/11/2000EP1042506A1 Reagents and methods useful for detecting diseases of the breast
10/11/2000EP1042498A1 A method of finding agonist and antagonist to human 11cb splice variant
10/11/2000EP1042492A1 Humanized monoclonal antibodies that protect against shiga toxin induced disease
10/11/2000EP1042485A2 Desaturase
10/11/2000EP1042480A1 Streptococcal heat shock proteins of the hsp60 family
10/11/2000EP1042479A1 A process for preparing human proinsulin
10/11/2000EP1042476A1 Insulin-like growth factor binding protein fragments and the utilization thereof
10/11/2000EP1042475A2 PEPTIDES AND NUCLEIC ACIDS DERIVED FROM $i(EISENIA FOETIDA) AND THE USE THEREOF
10/11/2000EP1042470A2 Bone marrow secreted proteins and polynucleotides
10/11/2000EP1042468A2 Low-voltage activated calcium channel compositions and methods
10/11/2000EP1042467A1 Non-identical genes and their application in improved molecular adjuvants
10/11/2000EP1042466A1 Polypeptides, polynucleotides and uses thereof
1 ... 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 ... 3163